These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bilateral 0.19 mg Fluocinolone Acetonide Intravitreal Implant in the Successful Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Secondary Macular Oedema: A Case Report and Review of Intravitreal Therapies. Ansari AS; Amir Z; Williams GS Ophthalmol Ther; 2021 Mar; 10(1):193-200. PubMed ID: 33464558 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months. Moll-Udina A; Hernanz I; Sainz-de-la-Maza M; Pelegrín L; Coelho-Borges AI; Pazos M; Adán A; Llorenç V Int Ophthalmol; 2023 Nov; 43(11):4181-4195. PubMed ID: 37698661 [TBL] [Abstract][Full Text] [Related]
6. The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India. Biswas J; Tyagi M; Agarwal M; Ophthalmol Sci; 2024; 4(1):100403. PubMed ID: 38027419 [TBL] [Abstract][Full Text] [Related]
7. Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye. Mikhail M; Sallam A Med Hypothesis Discov Innov Ophthalmol; 2013; 2(4):113-20. PubMed ID: 24822232 [TBL] [Abstract][Full Text] [Related]
9. Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pouwels XGLV; Petersohn S; Carrera VH; Denniston AK; Chalker A; Raatz H; Armstrong N; Shah D; Witlox W; Worthy G; Noake C; Riemsma R; Kleijnen J; Joore MA Pharmacoeconomics; 2020 May; 38(5):431-441. PubMed ID: 31701471 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758 [TBL] [Abstract][Full Text] [Related]
11. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis. ; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience. Kozak I; Gurbaxani A; Pandova M J Ophthalmic Inflamm Infect; 2024 Jun; 14(1):24. PubMed ID: 38833091 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment. Steeples LR; Pockar S; Jones NP; Leal I Clin Ophthalmol; 2021; 15():1433-1442. PubMed ID: 33854297 [TBL] [Abstract][Full Text] [Related]
17. Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sjögren's syndrome-related keratopathy: a case report. Wasielica-Poslednik J; Pfeiffer N; Gericke A J Med Case Rep; 2019 Jan; 13(1):21. PubMed ID: 30674351 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients. Studsgaard A; Clemmensen KØ; Nielsen MS Graefes Arch Clin Exp Ophthalmol; 2022 May; 260(5):1633-1639. PubMed ID: 34851465 [TBL] [Abstract][Full Text] [Related]
19. A New Approach for Diabetic Macular Edema Treatment: review of clinical practice results with 0.19 mg fluocinolone acetonide intravitreal implant including vitrectomized eyes. Estebainha R; Goldhardt R; Falcão M Curr Ophthalmol Rep; 2020 Mar; 8(1):1-10. PubMed ID: 32346496 [TBL] [Abstract][Full Text] [Related]
20. Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report. Meira J; Madeira C; Falcão-Reis F; Figueira L Ophthalmol Ther; 2019 Dec; 8(4):635-641. PubMed ID: 31506865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]